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Summary A case-control study of 913 black cancer patients (aged 15-50 years) was undertaken to measure the association between
human immunodeficiency (HIV) infection and cancers believed to have an infective aetiology. Controls were patients with cancers believed
not to be infective in origin. The prevalence of HIV in the controls of 7.3% (24 of 325) was similar to the background HIV seropositivity in this
population. Odds ratios (ORs) and 95% confidence intervals (Cl) adjusted for age, year of diagnosis, marital status and sex were calculated.
There was a strong association between HIV infection and Kaposi's sarcoma (KS), with 27 of 33 cases being HIV seropositive, OR = 61.8
(95% Cl 19.7-194.2) and an elevated association with non-Hodgkin's lymphoma (NHL), with 27 of 40 cases being HIV seropositive [OR = 4.8
(95% Cl 1.5-14.8)]. The elevated odds ratio for KS associated with HIV infection accords with the observed increases in the incidence of KS
in several sub-Saharan African countries where the prevalence of HIV is high. The odds ratio for NHL associated with HIV infection was lower
than that reported in developed countries, and the reason for this is not clear. No other cancers, including cervical and liver cancers, showed
significantly elevated odds ratios associated with HIV infection.
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The association between infectious agents and a number of
cancers has been documented elsewhere (Weiss, 1984; Zur-
Hausen, 1991). In South Africa about a third of the female and a
sixth ofthe male cancers are thought to be infective in origin (Sitas
et al, 1996). HIV-induced immune suppression in populations with
a high prevalence of HIV has led to an increased incidence of a
number of these infection-associated cancers, notably Kaposi's
sarcoma (KS) and non-Hodgkin lymphoma (NHL) (and perhaps
other cancers) in, for example, San Francisco single men (Rabkin
et al, 1994) and sub-Saharan Africa (Bourdeaux et al, 1988;
Wabinga et al, 1993; Bassett et al, 1995). In South Africa, the first
notifications ofHIV were in 1981, butby 1994 the HIV seropreva-
lence in female antenatal clinic attenders in Johannesburg and
Soweto had increased to 7.9% in blacks and 0.6% in whites
(Department of Health, 1995). An attempt was therefore made to
quantify the association between HIV infection and certain infec-
tion-related cancers.
MATERIALS AND METHODS
The study, which was approved by the University of the
Witwatwersrand Ethics Committee, was conducted between
Received2 October 1996
Revised22 November 1996
Accepted26 November 1996
Correspondence to: F Sitas
mid-1992 and December 1995 at the three major public referral
hospitals for cancer patients in the Greater Johannesburg
Metropole, namely Johannesburg Hospital, Hillbrow Hospital
(also in Johannesburg) and Baragwanath Hospital in Soweto.
A blood sample was taken fromblackpatients aged 15-50 years
(the age andpopulation group most likely to be infected by HIV at
this stage ofthe epidemic) diagnosed forthe first time with cancer.
Serum was separated and stored at-30°C and tested anonymously
for the presence ofHIV. Until mid-1995, subjects were considered
to be HIV positive if a positive enzyme-linked immunosorbent
assay (ELISA) was confirmed by a Westem blot, immunofluores-
cent assay (IFA) or by another ELISA (Abbott EIA-IMX). Since
mid-1995, the World Health Organization (WHO) (1992) recom-
mended protocol of three third-generation ELISA tests to confirm
HIV-positive results was used.
Patient information collected from clinical notes included age,
sex, marital status, area ofresidence, dates ofdiagnosis and treat-
ment, primary site, morphology and method of diagnosis (for
example, clinical examination, histology of primary, cytology,
autopsy, etc.). Cancers were coded according to their primary site
and morphology using the Intemational Classification ofDiseases
-Oncology, second revision manual (ICDO-2) (Percy et al, 1990).
Duplicate entries were deleted on the basis of the patient's demo-
graphic and cancer details.
'Cases' comprised those cancers believed to have an infectious
cause, namely Kaposi's sarcoma, all haematological malignancies,
cervical, anal and liver cancers (Beral, 1991; Rabkin and Blattner,
1991). In addition, certain cancers were added to the case group
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because of varying degrees of suspicion of an infectious cause
namely stomach (International Agency for Research on Cancer,
1994), oral (International Agency for Research on Cancer, 1995),
oesophageal (Dillner et al, 1995), squamous cell skin, penile and
vaginal cancers (Zur Hausen, 1991). 'Controls' comprised patients
with cancers other than those suspected to have an infectious cause
(see Table 1 for list). The choice of controls comprising cancers
other than those thought to be associated with the exposure of
interest has been used successfully in other contexts (tobacco,
alcohol) (Barra et al, 1991; Parkin et al, 1994) and in Rwanda
(infection-related cancers) (Newton et al, 1995).
Unmatched unconditional maximum-likelihood logistic regres-
sion (PROC LOGISTIC, SAS, 1988) was used to calculate odds
ratios (ORs), 95% confidence intervals (95% CI) and two-sided P-
values (2P), adjusted for age (15-34, 35-50 years), sex, marital
status (never married, other) and year ofdiagnosis (before and after
December 1994). A separate term was included for each adjust-
ment factor in the regression formula. No adjustments were made
to the significance values to account for multiple comparisons.
RESULTS
Most (94.3%) cancer diagnoses were verified by histology, haema-
tology or cytology. Among the controls (Table 1), the seropreva-
lence of HIV (5.6% in men and 8.3% in women) was similar to the
HIV seroprevalence of a group of regularly surveyed black male
blue collar municipal workers (5.8% in 1994; B Schoub, personal
communication) and of black women attending antenatal clinics
(7.9% in 1994; Department of Health, 1995) in this province. In
the case group, the seroprevalence of HIV was 12.9% in men and
10.9% in women.
Fourteen of seventeen men with KS were HIV seropositive
(82.4%) compared with 5.6% in male controls, OR = 231.4 (95%
CI 16.5-3255.3); 13 of 16 (81.3%) women with KS were HIV
seropositive compared with 7.8% in female controls, OR = 52.6
(95% CI 11.5-241.3). However, there was no significant differ-
ence in the odds ratio between men and womnen (Breslow-Day test
for homogeneity, P = 0.6). Three of twenty-seven men (11.1%)
and 4 of 13 female patients (30.8%) with NHL were HIV seropos-
itive. The OR of HIV in NHL was 4.8 (95% CI 1.5-14.8) in both
sexes combined, 2.4 (95% CI 0.4-15.3) in men and 12.0 (95% CI
2.6-56.7) in women. The difference in the OR between men and
women, however, was not significant (Breslow Day test forhomo-
geneity, P = 0.4). No other cancers showed significant associa-
tions with HIV infection. Notably, the prevalence of HIV in
women with cancer ofthe cervix was non-significantly lower than
in controls (7 of 180, 3.9%), OR = 0.6 (95% CI 0.2-1.9) and there
was no significant association between HIV infection and cancer
ofthe liver, OR = 0.9 (95% CI 0.3-2.9).
DISCUSSION
The odds ratio for developing KS in relation to HIV infection in
this study of 61.8 (95% CI 19.7-194.2) for men and women
combined was broadly similar to the odds found in the only other
comparable study from Rwanda (Newton et al, 1995) (OR = 35.0;
95% CI 8.2-206.7). Although statistically non-significant, the
greater odds ofdeveloping KS in relation to HIV infection in men,
231.4 compared with 52.6 for women is noteworthy and could be
as a result of the epidemiology of Kaposi's sarcoma-associated
herpesvirus (Chang et al, 1994) or other factors. In areas of high
HIV seroprevalence, KS shows a dramatic increase and it is now
Table 1 Association between HIV and cancers believed to have an infectious cause
Sex na HIV positive (%) ORb 95% CIb 2P
Controlsc Male 107 5.6 - - -
Female 218 8.3 - -
Kaposi's sarcomad Both 33 81.8 61.8 19.7-194.2 0.0001
Non-Hodgkin's lymphoma Both 40 17.5 4.8 1.5-14.8 0.007
Liver Both 64 6.2 0.9 0.3-2.9 0.9
Cervix Female 180 3.9 0.6 0.2-1.9 0.4
Oral Both 22 9.1 1.1 0.1-9.3 1.0
Naso, oropharynx Both 4 0.0 - -
Oesophagus Both 52 3.9 0.8 0.2-3.7 0.8
Stomach Both 18 5.6 1.2 0.9-1.7 0.9
Anus Both 4 0.0 - - -
Squamous cell skin Both 12 8.3 1.5 0.2-14.6 0.7
Vagina Female 18 22.2 3.2 0.8-13.3 0.1
Penis Male 2 0.0 - - -
Burkitt's lymphomad Female 1 100.0 °°-
Leukaemiad Both 78 7.7 1.2 0.4-3.6 0.7
Hodgkin's lymphomad Both 37 10.8 2.0 0.6-6.6 0.3
Haematological otherd Both 22 0.0 - -
an, total number of patients. Information on age, sex, marital status and diagnosis year was available for 831 of 913 (91%) patients. No information on marital
status of liver cancer patients was available. bOdds ratio and 95% confidence intervals adjusted for age, sex (when applicable), diagnosis year and marital
status. cThe distribution of cancers in the controls and their HIV seroprevalence was as follows: intestine and peritoneum, 34 (5.9%); gall bladder, 3 (0%);
pancreas, 4 (0%); lung, 37 (2.7%); other respiratory, 7 (0%); bone, 8 (0%); melanoma, 9 (11.1%); basal and non-squamous cell cancers, 1.1%, connective
tissue, 5 (20%); female breast, 86 (10.5%); corpus uteri and uterus not otherwise stated, 10 (0%); ovary, 26 (15.4%); placenta, 2 (0%); prostate, 4 (0%); testis, 2
(50%); urinary, 16 (0%); eye (rhabdomyosarcoma), 1 (0%); brain and CNS, 4 (0%); endocrine, 14 (0%); primary unknown, 42 (9.5%). dlCDO-2 codes were:
Kaposi's sarcoma, M9170; Non-Hodgkin lymphoma, M9590, 9670-9686, 9690-9698, 9701-9707, 9711-9714, 9720-9723; Burkitt's lymphoma, M9687;
leukaemia, M9800-9804, 9820-9827, 9830, 9840-9842, 9850, 9860-9868, 9870, 9880, 9890-9894, 9900-9941, 9950-9970, 9980-9989; Hodgkin's
lymphoma, M9650-9667; haematological other, 9731, 9760, 9762, 9763, 9765-9768; squamous cell skin, C44. - and M8070-8072, 8560.
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the commonest cancer in African men in Kampala (48% of all
cancers) and in Harare (23.3%) and is a common cancer in women
in Kampala (17.6%; Wabinga et al, 1993) and in Harare (9.9%;
Bassett et al, 1995). In Western countries, young single men, for
example in San Francisco, have shown a 5000-fold increase in the
incidence of KS since the advent of HIV (Rabkin et al, 1991). In
contrast, in South Africa no increase in the incidence of KS was
observed between 1986 and 1991; the latest data available in the
pathology-based National Cancer Registry (Sitas et al, 1996) and
the ASIR (world) for KS in the period 1990-91 were still low
when compared with other sub-Saharan African countries (in
black men 0.71 and in black women 0.15 per 100 000), because
the South African HIV epidemic lags a few years behind these
countries (Doyle et al, 1991). However, the number of histologi-
cally diagnosed KS cases from Baragwanath hospital increased
from eight in 1989 (12 months) to 20 cases between January and
June 1996 (National Cancer Registry, unpublished data).
The odds ratio of NHL in association with HIV (men and
women combined) of 4.8 (95% CI 1.5-14.8) was lower than that
found in Rwanda, 12.6 (95% CI 2.2-54.4) (Newton et al, 1995)
but much lowerthan that observed in the USA ofaround 60 (Beral
et al, 1991). In the (South) African setting, persons may succumb
to other opportunistic infections before the onset ofNHL, but data
from transplant patients suggest that excesses of NHL occur even
6 months after the start of immunosuppressive treatment (Kinlen,
1992). Epstein Barr Virus (EBV) has been suspected as a cause of
NHL (Zur-Hausen, 1991; Kinlen, 1992; Lehtinen et al, 1993).
Acquisition of EBV in childhood (a common infection in Africa;
Zur-Hausen, 1991) may impart immunity to subsequent EBV
infection or may lead to less complicated pathology ifthe virus is
reactivated because ofimmune suppression. Evidence ofincreases
in the incidence ofNHL in sub-Saharan Africa is not clear, but in
Uganda (Wabinga et al, 1993) no increase in incidence of NHL
was observed between 1995 and 1992. Given the discrepancies in
the odds ratio for HIV-associated NHL between developed coun-
tries and Africa, it is unclear whether these findings are applicable
to South Africa's white population, which has a lifestyle closer
to populations from developed country settings. Until further
research is done these hypotheses will remain speculative.
The lackofan association between cancerofthe cervix and HIV
infection is consistent with data from Tanzania (ter Meulen et al,
1992) where the HIV epidemic has been present for longer than in
South Africa. No increases in incidence or relative frequency of
cancer of the cervix have been observed in South Africa (Sitas et
al, 1996) or in Zambia (Patil et al, 1995). In Kampala (Wabinga et
al, 1993), the incidence of cancer of the cervix doubled over a
20-year period, but this increase began before the advent of HIV.
No increases in mortality because of cancer of the cervix in
women aged 15-44 years residing in states with a high risk ofHIV
(Buehler et al, 1992) have been documented in the USA between
1979 and 1988.
Given the poor prognosis of persons infected with HIV, doctors
might be reluctant to refer HIV-positive individuals for additional
medical procedures. Obviously, we could not guard against such
referral bias, although, in most cases, given the academic interest in
cancer and HIV here, either afine-needle aspirate ora biopsy would
be taken if individuals (irrespective of their known HIV status)
exhibited significant symptoms, e.g. lymph node enlargement. The
relationships described between HIV infection and KS, NHL,
cancer ofthe cervix and liver appear to be in accord with what little
is known aboutthe epidemiology ofHIV and cancerin sub-Saharan
Africa. Larger studies are required to confirm these results and
possibly toreveal othernovel associations between HIV and cancer.
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